RxDoctor Payments DataLook up a doctor →

Seth Forman, MD

Dermatology · Tampa, FLNPI 1346304540

Payments from drug & device makers

$28,221,196in general payments, 2019–2025

Across 4,888 payments — averaging $5773.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$5.5M
  • Pfizer$4.2M
  • Janssen Research & Development, LLC$4M
  • Incyte Corporation$3.4M
  • UCB SA$3.1M
  • Modernatx, Inc.$2.5M
  • plus $5.6M from 54 others
$173,995in research payments, 2019–2025

Across 66 payments — averaging $2636.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$87K
  • Eli Lilly$85K
  • Regeneron$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly251$5,480,905
Pfizer757$4,157,930
Janssen Research & Development, LLC339$3,981,470
Incyte Corporation1,061$3,434,182
UCB SA124$3,133,627
Modernatx, Inc.922$2,474,135
Vertex2$1,909,241
AbbVie300$1,174,295
Tris Pharma Inc15$453,495
Regeneron161$277,786
Boehringer Ingelheim28$207,473
Lilly USA, LLC180$174,248
Biofrontera Bioscience GmbH6$140,958
Novartis80$137,704
Dermira, Inc.17$137,452
Amgen(2 entities)36$124,552
Almirall LLC26$122,786
Sun Pharmaceutical Industries Inc.80$116,967
Bristol Myers Squibb9$100,014
UCB Biosciences Inc.2$97,891
Sanofi US Services Inc.10$82,543
E.r. Squibb & Sons, L.L.C.50$57,010
Genentech, Inc.13$44,054
UCB, Inc.62$37,150
Arcutis Biotherapeutics, Inc.29$30,001
Teva Pharmaceuticals USA, Inc.5$24,591
Sanofi Pasteur Inc.4$19,381
Galderma Research & Development, LLC4$16,178
GSK6$15,193
AstraZeneca1$12,034
CSL Behring2$9,223
Biohaven Pharmaceutical Holding Company Ltd.3$7,205
Gilead1$6,000
Boehringer Ingelheim Espana S.A.3$4,955
Boehringer Ingelheim International GmbH4$4,326
Merz North America, Inc.26$3,582
Galderma Laboratories, L.p.21$2,747
Boehringer Ingelheim Canada Ltd.ltee14$2,345
Dr.reddy's Laboratories,inc.1$928
LEO Pharma Inc.35$758
Sanofi35$747
Regeneron Healthcare Solutions, Inc.29$589
Johnson & Johnson25$551
Ortho Dermatologics, A Division Of Bausch Health US, LLC20$323
Mayne Pharma Commercial LLC11$252
Dermavant Sciences, Inc.11$222
VYNE Pharmaceuticals Inc.8$153
EPI Health, LLC8$138
Genentech USA, Inc.9$134
Biofrontera Inc.5$88
Organon4$82
Fresenius Kabi USA, LLC4$77
Encore Dermatology Inc.5$73
Sandoz4$66
Botanix SB Inc3$57
Journey Medical Corporation3$56
Verrica Pharmaceuticals Inc.2$48
Organogenesis Inc.2$40
Aclaris Therapeutics, Inc.2$31
Eli Lilly Export S.A. Puerto Rico Branch1$27

How this compares

$28,221,196 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$203,660
Medicare patients
743
Services billed
5,590

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →